SMVSX
Price
$35.95
Change
-$0.43 (-1.18%)
Updated
Jul 13 closing price
Net Assets
11.34B
SSGSX
Price
$52.87
Change
-$0.12 (-0.23%)
Updated
Jul 13 closing price
Net Assets
4.55B
Interact to see
Advertisement

SMVSX vs SSGSX

SMVSX vs SSGSX Comparison Chart in %
View a ticker or compare two or three
VS
SMVSX vs. SSGSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SMVSX is a Hold and SSGSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SMVSX has more cash in the bank: 11.3B vs. SSGSX (4.55B). SSGSX pays higher dividends than SMVSX: SSGSX (0.51) vs SMVSX (0.41). SMVSX was incepted earlier than SSGSX: SMVSX (9 years) vs SSGSX (27 years). SSGSX (1.23) is less costly to investors than SMVSX (0.72). SMVSX is a more actively managed with annual turnover of: 79.00 vs. SSGSX (50.00). SSGSX has a lower initial minimum investment than SMVSX: SSGSX (2500) vs SMVSX (1000000). SMVSX annual gain was more profitable for investors over the last year : 36.44 vs. SSGSX (17.30). SMVSX return over 5 years is better than : 71.58 vs. SSGSX (-0.56).
SMVSXSSGSXSMVSX / SSGSX
Total Expense Ratio0.721.2359%
Annual Report Gross Expense Ratio0.721.2359%
Fund Existence9 years27 years-
Gain YTD27.91818.572150%
Front LoadN/A6%-
Min. Initial Investment1000000250040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets11.3B4.55B248%
Annual Yield % from dividends0.410.5180%
Returns for 1 year36.4417.30211%
Returns for 3 years77.3811.95648%
Returns for 5 years71.58-0.56-12,871%
Returns for 10 yearsN/A41.05-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ODMCX10.38N/A
N/A
JPMorgan SMID Cap Equity C
BMEAX26.96N/A
N/A
BlackRock High Equity Income Investor A
SMFAX28.21N/A
N/A
American Beacon Stephens Mid-Cap Gr A
NGJAX20.77N/A
N/A
Nuveen Global Real Estate Securities A
MFRHX59.66N/A
N/A
MFS Research R3